OS Therapies Incorporated (OSTX)
OSTX Stock Price Chart
Explore OS Therapies Incorporated interactive price chart. Choose custom timeframes to analyze OSTX price movements and trends.
OSTX Company Profile
Discover essential business fundamentals and corporate details for OS Therapies Incorporated (OSTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Aug 2024
Employees
5.00
Website
https://ostherapies.comCEO
Paul A. Romness
Description
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
OSTX Financial Timeline
Browse a chronological timeline of OS Therapies Incorporated corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Aug 2026
EPS estimate is -$0.25, while revenue estimate is $511.00k.
Earnings released on 18 May 2026
EPS came in at -$0.27 falling short of the estimated -$0.17 by -58.82%.
Earnings released on 31 Mar 2026
EPS came in at -$0.35 falling short of the estimated -$0.14 by -157.35%.
Earnings released on 14 Nov 2025
EPS came in at -$0.21 falling short of the estimated -$0.16 by -31.25%.
Earnings released on 19 Aug 2025
EPS came in at -$0.19 falling short of the estimated -$0.15 by -26.67%.
Earnings released on 15 May 2025
EPS came in at -$0.18 falling short of the estimated -$0.11 by -63.64%.
Earnings released on 31 Mar 2025
EPS came in at -$0.24 falling short of the estimated -$0.14 by -71.43%.
Earnings released on 15 Nov 2024
EPS came in at -$0.18 falling short of the estimated -$0.12 by -50.00%.
Earnings released on 14 Aug 2024
EPS came in at -$0.26 matching the estimated -$0.26, while revenue for the quarter reached $139.85k .
Earnings released on 20 May 2024
EPS came in at -$0.07 , while revenue for the quarter reached $132.00k .
Earnings released on 31 Dec 2023
EPS came in at -$0.07 .
Earnings released on 30 Sept 2023
EPS came in at -$0.09 .
Earnings released on 30 Jun 2023
EPS came in at -$0.00 .
Earnings released on 31 Mar 2023
EPS came in at -$0.00 .
Earnings released on 31 Dec 2022
EPS came in at -$0.00 .
Earnings released on 31 Mar 2022
EPS came in at -$0.00 .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 .
OSTX Stock Performance
Access detailed OSTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
